BofA acted as sole book running manager for the offering.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STRO:
- Sutro Biopharma Announces Pricing of $75 Million Underwritten Offering
- Sutro Biopharma Secures Major Deal with Ipsen for STRO-003
- Penny Stock Sutro Biopharma (NASDAQ:STRO): Intriguing Play for Biotech Investors
- Biotech Alert: Searches spiking for these stocks today
- Sutro Biopharma’s New Forum Selection Clause: Protecting Interests or Alienating Shareholders?